Company Filing History:
2 out of 151 
1 out of 2,488 
1 out of 1,157 Years Active: 2015-2016
Title: Paula Maria Wilhelmina Van Helden: Innovator in Immunology
Introduction
Paula Maria Wilhelmina Van Helden is a notable inventor based in Den Bosch, Netherlands. She has made significant contributions to the field of immunology, particularly in the development of therapies for hemophilia A. With a total of 2 patents, her work focuses on innovative solutions to improve patient outcomes.
Latest Patents
Her latest patents include the invention of FVIII peptides for immune tolerance induction and immunodiagnostics. This invention relates to peptides that can be utilized to reduce the immune response against FVIII or to induce tolerance to human FVIII in patients suffering from hemophilia A. Furthermore, these peptides serve immunodiagnostic purposes, enabling the detection of FVIII-specific CD4T cells. This monitoring is crucial for patients undergoing replacement therapy and immune tolerance induction therapy.
Career Highlights
Throughout her career, Paula has worked with prominent companies in the healthcare sector, including Baxalta GmbH and Baxter International Inc. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in medical treatments.
Collaborations
Paula has collaborated with esteemed colleagues such as Katharina Nora Steinitz and Birgit Maria Reipert. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking solutions in immunology.
Conclusion
Paula Maria Wilhelmina Van Helden is a pioneering inventor whose work in immunology has the potential to transform the treatment of hemophilia A. Her innovative patents and collaborations highlight her commitment to improving patient care and advancing medical science.